Minerva Neurosciences | NERV - Modal Saham Biasa





Modal Saham Biasa Perubahan Tanggal
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Adma Biologics USD 225.36M 6.93M 2026-06
ALKERMES USD 168.03M 489K 2026-09
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
AstraZeneca USD 1.55B 28K 2026-09
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Cipla INR 807.87M 88K 2026-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.72M 170K 2026-06
CSL USD 482.13M 93.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 113.94M 106K 2026-09
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
J&J USD 2.41B 1.64M 2026-06
Merck USD 2.47B 1.05M 2026-06
Minerva Neurosciences USD 1000 0 2024-09
Neurocrine Biosciences USD 101.3M 750K 2026-09
Novartis USD 1.89B 12.09M 2026-09
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 0 2026-09
Takeda JPY 1.58B 460K 2026-06
Vanda Pharmaceuticals USD 58K 0 2024-12